CLINICAL EFFICACY OF PROBIOTICS AS AN ADJUNCT TO ERADICATION THERAPY IN PEPTIC ULCER DISEASE
Abstract
Treatment of infection-related diseases Helicobacter pylori (NR), such as chronic gastritis and peptic ulcer disease, continues to be a complex medical problem, especially given that there are no methods that guarantee 100% success. In recent years, there has been a growing interest in researching the problems of insufficient effectiveness of eradication therapy (ET), which is confirmed by a significant number of meta-analyses and publications devoted to various aspects of this issue. In the 90s of the last century, the effectiveness of standard therapy regimens was about 90%, however, today in various countries, this figure rarely reaches 60% [1].
References
1. Mayov I.V., Samsonov A.A., Andreev D.N. Helicobacter pylori infection. M.: GEOTAR-Media, 2016.
2. Atkinson N.S., Braden B. Helicobacter Pylori infection: diagnostic strategies in primary diagnosis and after therapy // Dig. Dis. Sci. - 2016. - Vol. 61, No1. - P. 19-24.
3. Chey W.D., Leontiadis G.I., Howden C.W., Moss S.F. AC Clinical Guideline: Treatment of Helicobacter pylori infection // Amer. J. Gastroenterol. - 2017. - Vol. 112, No. - P. 212-239.
